BONO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.612
AS - Asia 2.000
EU - Europa 1.425
SA - Sud America 194
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 65
OC - Oceania 8
Totale 6.465
Nazione #
US - Stati Uniti d'America 2.522
IT - Italia 647
CN - Cina 572
SG - Singapore 562
BD - Bangladesh 246
VN - Vietnam 196
HK - Hong Kong 175
BR - Brasile 150
RU - Federazione Russa 124
GB - Regno Unito 104
NL - Olanda 101
DE - Germania 97
IN - India 84
FI - Finlandia 77
SE - Svezia 76
FR - Francia 75
CA - Canada 62
ID - Indonesia 39
KR - Corea 31
JP - Giappone 28
PL - Polonia 22
AT - Austria 20
IE - Irlanda 20
AR - Argentina 18
ZA - Sudafrica 17
CI - Costa d'Avorio 16
MX - Messico 16
ES - Italia 15
TR - Turchia 15
UA - Ucraina 9
AU - Australia 8
IQ - Iraq 8
PK - Pakistan 6
PT - Portogallo 6
ZW - Zimbabwe 6
CH - Svizzera 5
CO - Colombia 5
EC - Ecuador 5
ET - Etiopia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MY - Malesia 4
NG - Nigeria 4
PE - Perù 4
UZ - Uzbekistan 4
BE - Belgio 3
CL - Cile 3
KE - Kenya 3
LV - Lettonia 3
LY - Libia 3
MA - Marocco 3
NO - Norvegia 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
ZM - Zambia 2
AL - Albania 1
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GY - Guiana 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MQ - Martinica 1
MT - Malta 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.305
Città #
Dallas 376
Singapore 288
Ashburn 287
Milan 205
Chicago 198
Los Angeles 179
San Jose 154
Hong Kong 146
Hefei 135
Santa Clara 110
Beijing 87
Salt Lake City 77
New York 65
Council Bluffs 58
Buffalo 55
Ho Chi Minh City 54
Hanoi 49
Bengaluru 42
Rome 42
Helsinki 39
Boardman 36
Munich 35
Southend 34
Tampa 33
Lauterbourg 32
Elk Grove Village 31
Moscow 31
Frankfurt am Main 30
Sterling 30
Jakarta 29
Seoul 24
Phoenix 23
São Paulo 21
Dublin 20
Guangzhou 20
Lappeenranta 20
Montreal 19
Chandler 18
Seattle 18
Turku 18
Turin 17
Abidjan 16
Vienna 16
Atlanta 15
Shanghai 15
The Dalles 15
Tokyo 15
Warsaw 15
Wilmington 15
Naples 14
Poplar 14
Amsterdam 13
Da Nang 13
Haiphong 13
Istanbul 12
Miami 12
Toronto 12
Boston 11
Florence 11
Genoa 11
Lancaster 11
Bologna 10
Columbus 10
Fremont 10
Houston 10
Las Vegas 10
Memphis 10
Washington 10
Chennai 9
Coventry 9
Dulles 9
London 9
Nuremberg 9
Orem 9
Cangzhou 8
Düsseldorf 8
Johannesburg 8
San Francisco 8
Shenzhen 8
Brooklyn 7
Camaiore 7
Denver 7
Nanjing 7
Perugia 7
Coyoacán 6
Detroit 6
Harare 6
Paris 6
Pittsburgh 6
Princeton 6
Quanzhou 6
Stockholm 6
Baghdad 5
Bari 5
Bắc Ninh 5
Fuzhou 5
Hải Dương 5
Mexico City 5
Mumbai 5
Newark 5
Totale 3.741
Nome #
Inflammation and Intracellular Exposure of Dolutegravir, Darunavir, Tenofovir and Emtricitabine in People living with HIV 489
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 386
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection 303
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 295
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 274
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19 267
Impairment of platelet function in both mild and severe COVID-19 patients 265
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir 227
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 224
Predictors of low ovarian reserve in cART-treated women living with HIV 223
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 219
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease 214
Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects 210
Immunological recovery with BIC/FTC/TAF: CD4 T-cell count and CD4/CD8 ratio as markers of response 203
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV 202
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? 202
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 200
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients 181
Association between tight junction proteins and cognitive performance in untreated persons with HIV 165
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection 152
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors 152
INFLAMMATORY AND T-CELL HOMEOSTASIS PARAMETERS IN DUAL AND TRIPLE COMBINATION ANTIRETROVIRAL THERAPY (CART) FOR HIV INFECTION 146
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 139
Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV 133
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 127
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV 120
Failure of CD4+ T-cell recovery upon virally-effective cART : an enduring gap in the understanding of HIV+ immunological non-responders 119
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 114
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19 114
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 101
Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract 89
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape 78
Bridging the gap: addressing real-life challenges to the implementation of DTG/3TC in treatment-naive people living with HIV 60
Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio Registry 44
Astrocyte/monocyte activation and inflammation are associated with asymptomatic neurocognitive impairment in people with HIV on suppressive antiretroviral therapy 28
Totale 6.465
Categoria #
all - tutte 18.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 0 9 3 10 10 9 9 6 25 3 2 11
2022/2023181 6 3 3 11 16 33 19 9 23 3 35 20
2023/2024411 36 17 20 23 50 40 49 36 11 20 58 51
2024/20251.804 40 91 33 92 61 62 47 60 54 369 281 614
2025/20263.662 257 475 427 348 244 193 400 152 262 227 415 262
2026/2027272 201 71 0 0 0 0 0 0 0 0 0 0
Totale 6.465